Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice

Aging Cell

Volumn 12, Issue 3, 2013, Pages 345-357

  Jackaman, Connie ^a   Radley Crabb, Hannah G ^a   Soffe, Zoe ^b   Shavlakadze, Tea ^b   Grounds, Miranda D ^b   Nelson, Delia J ^a  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Aging; Cancer immunotherapy; CD40; Interleukin 2; Macrophage

Indexed keywords

ANTIBODY; CD40 ANTIBODY; GAMMA INTERFERON; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL SUBPOPULATION; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; IMMUNE DEFICIENCY; IMMUNOTHERAPY; INTERFERON PRODUCTION; LUNG CARCINOMA; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MESOTHELIOMA; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; SPLEEN; SUPPRESSOR CELL; TUMOR MICROENVIRONMENT;

AGING; ANIMALS; ANTIGENS, CD40; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL AGING; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-4; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MESOTHELIOMA; MICE; MICE, INBRED C57BL; RECEPTORS, CHEMOKINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR MICROENVIRONMENT;

MUS;

EID: 84877798009     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.12062     Document Type: Article

References (45)

1. Allavena P, Sica A, Garlanda C, Mantovani A (2008) The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol. Rev. 222, 155-161.
2. Alvarez-Rodriguez L, Lopez-Hoyos M, Munoz-Cacho P, Martinez-Taboada VM (2012) Aging is associated with circulating cytokine dysregulation. Cell. Immunol. 273, 124-132.
3. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B (2007) Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204, 1057-1069.
4. Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, Bottazzi B, Doni A, Vincenzo B, Pasqualini F, Vago L, Nebuloni M, Mantovani A, Sica A (2006) A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood 107, 2112-2122.
5. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, Yu W, Rongione MA, Ekstrom TJ, Harris TB, Launer LJ, Eiriksdottir G, Leppert MF, Sapienza C, Gudnason V, Feinberg AP (2008) Intra-individual change over time in DNA methylation with familial clustering. JAMA 299, 2877-2883.
6. Boehmer ED, Goral J, Faunce DE, Kovacs EJ (2004) Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression. J. Leukoc. Biol. 75, 342-349.
7. Dace DS, Apte RS (2008) Effect of senescence on macrophage polarization and angiogenesis. Rejuvenation Res. 11, 177-185.
8. Doyle KP, Cekanaviciute E, Mamer LE, Buckwalter MS (2010) TGF β signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J. Neuroinflammation 7, 62.
9. Effros RB, Dagarag M, Spaulding C, Man J (2005) The role of CD8 + T-cell replicative senescence in human aging. Immunol. Rev. 205, 147-157.
10. Fitzpatrick DR, Bielefeldt-Ohmann H, Himbeck RP, Jarnicki AG, Marzo AL, Robinson BW (1994) Transforming growth factor-beta: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and tumor-infiltrating T-cells in malignant mesothelioma. Growth Factors 11, 29-44.
11. Fraser CK, Brown MP, Diener KR, Hayball JD (2010) Unravelling the complexity of cancer-immune system interplay. Expert Rev. Anticancer Ther. 10, 917-934.
12. Fulop T, Kotb R, Fortin CF, Pawelec G, de Angelis F, Larbi A (2010) Potential role of immunosenescence in cancer development. Ann. N. Y. Acad. Sci. 1197, 158-165.
13. Gregg R, Smith CM, Clark FJ, Dunnion D, Khan N, Chakraverty R, Nayak L, Moss PA (2005) The number of human peripheral blood CD4 + CD25high regulatory T cells increases with age. Clin. Exp. Immunol. 140, 540-546.
14. Guiducci C, Vicari AP, Sangaletti S, Trinchieri G, Colombo MP (2005) Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res. 65, 3437-3446.
15. Haynes L, Maue AC (2009) Effects of aging on T cell function. Curr. Opin. Immunol. 21, 414-417.
16. Jackaman C, Nelson DJ (2010) Cytokine-armed vaccinia virus infects the mesothelioma tumor microenvironment to overcome immune tolerance and mediate tumor resolution. Cancer Gene Ther. 17, 429-440.
17. Jackaman C, Nelson DJ (2011) Intratumoral interleukin-2/agonist CD40 antibody drives CD4(+)-independent resolution of treated-tumors and CD4 (+)-dependent systemic and memory responses. Cancer Immunol. Immunother. 61, 549-560.
18. Jackaman C, Bundell CS, Kinnear BF, Smith AM, Filion P, van Hagen D, Robinson BW, Nelson DJ (2003) IL-2 intratumoral immunotherapy enhances CD8 + T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2. J. Immunol. 171, 5051-5063.
19. Jackaman C, Lew AM, Zhan Y, Allan JE, Koloska B, Graham PT, Robinson BW, Nelson DJ (2008) Deliberately provoking local inflammation drives tumors to become their own protective vaccine site. Int. Immunol. 20, 1467-1479.
20. Jackaman C, Cornwall S, Lew AM, Zhan Y, Robinson BW, Nelson DJ (2009) Local effector failure in mesothelioma is not mediated by CD4 + CD25 + T-regulator cells. Eur. Respir. J. 34, 162-175.
21. Jackaman C, Lansley S, Allan JE, Robinson BW, Nelson DJ (2012a) IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase. Int. Immunol. 24, 357-368.
22. Jackaman C, Majewski D, Fox SA, Nowak AK, Nelson DJ (2012b) Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo. Cancer Immunol. Immunother. 61, 2343-2356.
23. Leibovici J, Itzhaki O, Kaptzan T, Skutelsky E, Sinai J, Michowitz M, Asfur R, Siegal A, Huszar M, Schiby G (2009) Designing ageing conditions in tumour microenvironment-a new possible modality for cancer treatment. Mech. Ageing Dev. 130, 76-85.
24. Lung TL, Saurwein-Teissl M, Parson W, Schonitzer D, Grubeck-Loebenstein B (2000) Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine 18, 1606-1612.
25. Ly LV, Baghat A, Versluis M, Jordanova ES, Luyten GP, van Rooijen N, van Hall T, van der Velden PA, Jager MJ (2010) In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages. J. Immunol. 185, 3481-3488.
26. Lyons AB, Parish CR (1994) Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171, 131-137.
27. Mahbub S, Deburghgraeve CR, Kovacs EJ (2012) Advanced age impairs macrophage polarization. J. Interferon Cytokine Res. 32, 18-26.
28. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686.
29. Mantovani A, Sica A, Allavena P, Garlanda C, Locati M (2009) Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum. Immunol. 70, 325-330.
30. Movahedi K, Laoui D, Gysemans C, Baeten M, Stange G, van den Bossche J, Mack M, Pipeleers D, In't Veld P, de Baetselier P, van Ginderachter JA (2010) Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 70, 5728-5739.
31. Pelegrin P, Surprenant A (2009) Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J. 28, 2114-2127.
32. Ruckh JM, Zhao JW, Shadrach JL, van Wijngaarden P, Rao TN, Wagers AJ, Franklin RJ (2012) Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 10, 96-103.
33. Seth A, Nagarkatti M, Nagarkatti PS, Subbarao B, Udhayakumar V (1990) Macrophages but not B cells from aged mice are defective in stimulating autoreactive T cells in vitro. Mech. Ageing Dev. 52, 107-124.
34. Sharma S, Dominguez AL, Lustgarten J (2006) Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB. Exp. Gerontol. 41, 78-84.
35. Shavlakadze T, McGeachie J, Grounds MD (2010) Delayed but excellent myogenic stem cell response of regenerating geriatric skeletal muscles in mice. Biogerontology 11, 363-376.
36. Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S (2007) Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J. Immunol. 179, 977-983.
37. Smallwood HS, Lopez-Ferrer D, Squier TC (2011) Aging enhances the production of reactive oxygen species and bactericidal activity in peritoneal macrophages by upregulating classical activation pathways. Biochemistry 50, 9911-9922.
38. Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK, Suttles J (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175, 342-349.
39. Tsai CS, Chen FH, Wang CC, Huang HL, Jung SM, Wu CJ, Lee CC, McBride WH, Chiang CS, Hong JH (2007) Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth. Int. J. Radiat. Oncol. Biol. Phys. 68, 499-507.
40. Walsh JE, Young MR (2010) Interrelationship between protein phosphatase 1 and TGF-beta in regulating motility and cytoskeletal architecture of endothelial cells. Anticancer Res. 30, 4861-4866.
41. Warrington KJ, Vallejo AN, Weyand CM, Goronzy JJ (2003) CD28 loss in senescent CD4 + T cells: reversal by interleukin-12 stimulation. Blood 101, 3543-3549.
42. Watkins SK, Egilmez NK, Suttles J, Stout RD (2007) IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo. J. Immunol. 178, 1357-1362.
43. Yuan R, Tsaih SW, Petkova SB, Marin de EC, Xing S, Marion MA, Bogue MA, Mills KD, Peters LL, Bult CJ, Rosen CJ, Sundberg JP, Harrison DE, Churchill GA, Paigen B (2009) Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels. Aging Cell 8, 277-287.
44. Zhang Y, Acuna CL, Switzer KC, Song L, Sayers R, Mbawuike IN (2000) Corrective effects of interleukin-12 on age-related deficiencies in IFN-gamma production and IL-12Rbeta2 expression in virus-specific CD8 + T cells. J. Interferon Cytokine Res. 20, 235-245.
45. Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G (2008) Immunological aspects of cancer chemotherapy. Nat. Rev. Immunol. 8, 59-73.